Correlation Between Delaware Healthcare and Guidepath Growth

Can any of the company-specific risk be diversified away by investing in both Delaware Healthcare and Guidepath Growth at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Delaware Healthcare and Guidepath Growth into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Delaware Healthcare Fund and Guidepath Growth Allocation, you can compare the effects of market volatilities on Delaware Healthcare and Guidepath Growth and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Delaware Healthcare with a short position of Guidepath Growth. Check out your portfolio center. Please also check ongoing floating volatility patterns of Delaware Healthcare and Guidepath Growth.

Diversification Opportunities for Delaware Healthcare and Guidepath Growth

0.72

Correlation Coefficient

Delaware Healthcare  Guidepath Growth

Poor diversification

The 3 months correlation between Delaware and Guidepath is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Delaware Healthcare Fund and Guidepath Growth Allocation in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Guidepath Growth All and Delaware Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Delaware Healthcare Fund are associated (or correlated) with Guidepath Growth. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Guidepath Growth All has no effect on the direction of Delaware Healthcare i.e., Delaware Healthcare and Guidepath Growth go up and down completely randomly.

Pair Corralation between Delaware Healthcare and Guidepath Growth

Assuming the 90 days horizon Delaware Healthcare is expected to generate 1.39 times less return on investment than Guidepath Growth. In addition to that, Delaware Healthcare is 1.48 times more volatile than Guidepath Growth Allocation. It trades about 0.1 of its total potential returns per unit of risk. Guidepath Growth Allocation is currently generating about 0.2 per unit of volatility. If you would invest  1,835  in Guidepath Growth Allocation on May 18, 2025 and sell it today you would earn a total of  155.00  from holding Guidepath Growth Allocation or generate 8.45% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Delaware Healthcare Fund  vs.  Guidepath Growth Allocation

Delaware Healthcare

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in Delaware Healthcare Fund are ranked lower than 7 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong technical indicators, Delaware Healthcare is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Guidepath Growth All

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Guidepath Growth Allocation are ranked lower than 15 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Guidepath Growth may actually be approaching a critical reversion point that can send shares even higher in September 2025.

Pair Trading with Delaware Healthcare and Guidepath Growth

The main advantage of trading using opposite Delaware Healthcare and Guidepath Growth positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Delaware Healthcare position performs unexpectedly, Guidepath Growth can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Guidepath Growth will offset losses from the drop in Guidepath Growth's long position.

The idea behind Delaware Healthcare Fund and Guidepath Growth Allocation pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.